Why metformin matters beyond diabetes: New target could reshape aging and cancer research

AI Summary

Research at Université de Montréal uncovered how metformin, a common diabetes drug, works at a molecular level. The findings could influence aging and cancer research by revealing mechanisms that may reduce cancer risk and extend lifespan.

Scientists at Université de Montréal have figured out how metformin—a common drug that's used to treat type-2 diabetes and that may cut the risk of developing cancer and even help humans and other mammals live longer—actually works.